Compound ID | 139
Class: Isothiazoloquinolone
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Broad spectrum activity |
Institute where first reported: | Achillion Pharmaceuticals, USA (outsourced to Ora, Inc.) |
Year first mentioned: | 2008 |
Highest developmental phase: | Preclinical |
Development status: | Active |
Chemical structure(s): | |||||||||||
|
|